B2B SaaS · Seed to Series A

The hard part isn't fixing growth. It's knowing what to fix.

I diagnose revenue engines for B2B SaaS founders whose product works but whose growth resets every quarter. Plain language, your actual numbers, and the one thing to fix first, not a deck of nine.

No pitch. If it isn't a fit, I'll tell you on the call.

14
Years operating
150+
Founder and user conversations
Pipeline growth, eight months
3
Engagements at a time
The problem

Product works. Growth doesn't repeat.

Three patterns turn up in almost every founder diagnostic. If one of them reads like a description of your last two quarters, the conversation is already useful.

Lead quality

Leads arrive. Conversion doesn't move.

The dashboard looks healthy and closed-won doesn't budge. The cause is almost always upstream: ICP drift, channel mix, or a qualification step nobody has written down, and no one has named it out loud.

Motion

Every quarter is a different playbook.

Outbound this month, content next month, partnerships after that. No motion gets six clear months to compound, so nothing compounds, and each reset looks like bad luck rather than a pattern.

Revenue math

Growth happens. It doesn't repeat.

One quarter lands on a single large logo. The next resets to zero. The system isn't producing revenue. People are, manually, one deal at a time, and that ceiling arrives faster than anyone plans for.

One engagement, in full

7× pipeline in eight months, with no new headcount.

A Series A B2B SaaS company in India, twenty to sixty people. Named only by category. Client work stays confidential unless a client puts their name to it in writing.

The situation

Pipeline had been flat for two quarters. Founder-led selling had saturated, spend was climbing, conversion wasn't moving. The team believed it was a lead-volume problem.

What was actually wrong

Two levers were leaking at once, which is why single fixes kept failing. Targeting pulled in accounts that could never convert, so effort scaled while outcomes didn't. Underneath it, pricing and packaging were misaligned with the value delivered, so even the right accounts stalled at the commercial step. Volume was never the constraint. Architecture was.

What changed

Three moves, in sequence. The path to first value was rebuilt around a single activation moment. The funnel was instrumented end to end, every stage with one owner and one number, which turned argument into evidence. Pricing and packaging were rebuilt to match value captured to value delivered.

The result

Pipeline 7× in eight months. Conversion up 45%. Retention held at 92% through the scale-up, which is the part most teams break. First visible win landed inside thirty days, with no additional headcount, no engineering resource, and active internal resistance at the start.

The method

A nine-stage teardown, run in sequence.

Not a workshop and not a deck. Nine stages against your business, producing a named bottleneck, a sequence of moves, and a system that survives after the engagement ends.

  1. 01

    Context mapping

    Stage, motion, constraints, capital runway. The honest picture before any tactics.

  2. 02

    ICP and demand audit

    Who actually buys, who churns, and who you keep targeting for the wrong reason.

  3. 03

    Revenue stack diagnostic

    Funnel by funnel. Where pipeline leaks, where deals stall, where the motion breaks.

  4. 04

    Positioning and narrative

    What you sell versus what buyers hear. Usually two different products.

  5. 05

    Channel economics

    What works, what is vanity, what is missing. CAC against real cohort retention.

  6. 06

    Motion design

    Founder-led, sales-led, product-led. The right one for this stage, not the next one.

  7. 07

    Activation and retention

    Day 1 to Day 90. Where activation breaks before expansion is even possible.

  8. 08

    Pricing and packaging

    Value capture, plan structure, expansion path. Repriced against what buyers will pay.

  9. 09

    Governance and risk

    Metrics that matter, weekly cadence, decision rights. So the system holds after I leave.

Phase one · four weeks

The diagnostic

Two weeks gathering evidence, one turning it into settled decisions, one putting the first play into live operation, so something is moving before the phase ends rather than after it.

Phase two · monthly

The execution

Plays run, measured, then scaled or dropped on evidence. Conditional on the phase-one readout, never committed up front. You decide with the findings in front of you.

Fit

When not to hire me.

I take three engagements at a time, so a bad fit costs both of us more than it costs to say no early. Five situations where I am the wrong call.

  • 01You are pre-product or pre-revenue. There is no engine to diagnose yet, and I would be guessing alongside you.
  • 02You cannot give me access to your analytics and your numbers. The whole method is evidence. Without data I am just another opinion.
  • 03You want someone to execute a plan you have already decided on. Hire an operator or an agency. I would be the expensive way to do that.
  • 04You need the answer this week. The diagnostic runs four weeks because that is how long the evidence takes.
  • 05You are looking for reassurance. I will tell you which of your current bets is wrong, and that conversation is uncomfortable before it is useful.
Enterprise track record

Enterprise accounts I sold into and closed.

Seven years in enterprise B2B sales, 2012 to 2019, before I moved into SaaS growth. Every name here is a deal I worked, not a client list I inherited.

UnileverCastrolTata MotorsUltraTechAditya Birla ChemicalsCoca-ColaPepsiCamlin Fine SciencesRelianceTata ChemicalsTata CoffeeMaricoAmazonGlenmarkSun PharmaAsian PaintsCiplaWelspunUPLTeva PharmaQuintilesNPCIFiatPiaggioDB SchenkerRadio MirchiArkemaMahindraJSW SteelGodrejDaburEmamiJohn DeereForbes MarshallUnileverCastrolTata MotorsUltraTechAditya Birla ChemicalsCoca-ColaPepsiCamlin Fine SciencesRelianceTata ChemicalsTata CoffeeMaricoAmazonGlenmarkSun PharmaAsian PaintsCiplaWelspunUPLTeva PharmaQuintilesNPCIFiatPiaggioDB SchenkerRadio MirchiArkemaMahindraJSW SteelGodrejDaburEmamiJohn DeereForbes MarshallUnileverCastrolTata MotorsUltraTechAditya Birla ChemicalsCoca-ColaPepsiCamlin Fine SciencesRelianceTata ChemicalsTata CoffeeMaricoAmazonGlenmarkSun PharmaAsian PaintsCiplaWelspunUPLTeva PharmaQuintilesNPCIFiatPiaggioDB SchenkerRadio MirchiArkemaMahindraJSW SteelGodrejDaburEmamiJohn DeereForbes Marshall
Terms

The commercial terms, before you ask.

The guarantee
If the diagnostic doesn't identify leaks worth at least ten times the fee in annualised impact, half the fee comes back.
Payment
Diagnostic is prepaid in full. Longer engagements are 50% on signature, 50% on delivery. Bank transfer, exclusive of applicable taxes.
Capacity
Three engagements at a time. That constraint is what allows the work the depth it needs, and it means I sometimes say no.
The first call
Thirty minutes, free, no pitch. If the fit is wrong I say so on the call rather than sell you a diagnostic you don't need.
What you keep
Documented procedures your team runs without me. I'd rather an engagement ends with you not needing it than run indefinitely.
Availability

Currently taking new engagements.

Rohit Rohinkar
Who you'd be working with

Operator first. Consultant second.

Fourteen years operating. Seven selling into enterprise buyers, then seven inside B2B SaaS running product, growth and revenue motion. Not advising from the outside: building, shipping and owning the number, including the quarters where the number was wrong.

I have run both product-led and sales-led motions in the same company, which is rarer here than it should be, and it is usually the first real question: whether what you have is genuinely self-serve, or sales-assisted wearing a free tier.

I also built a company from zero and wound it down when the unit economics would not support venture-scale growth. The discipline to stop is part of the judgment I bring to other people's businesses.

Questions

Asked before every engagement.

Who is this for?+

B2B SaaS founders, typically Seed to pre-Series A, in India and abroad. Working product, real customers, unpredictable growth. If you are pre-product, this is not the right fit and I will say so.

How does an engagement start?+

A free thirty-minute call. We talk about the actual situation, not a pitch. If the fit is wrong I will tell you on the call. If it is right, you will have a clear next step before we hang up.

What does the diagnostic produce?+

Three named bottlenecks ranked by revenue impact, what each one costs you per quarter, a ninety-day sequenced build map with owners and dates, and one leak fixed with you inside the engagement window.

Do you only work with Indian companies?+

No. Engagements run across India, the US, the UK and the Middle East. The method does not change. The market context does, and that gets accounted for in the first stage.

Why should I trust a diagnosis from someone I have not worked with?+

You should not, on faith. Read what I publish, then judge whether the thinking is sharp enough to pay for. That is why the writing is public and the first call is free.

Next step

Thirty minutes. One honest read on what's actually broken.

If the fit is wrong I will tell you on the call. If it is right, you will leave with a sharper view of the bottleneck than you came in with.

cal.com/rohit-rohinkar/intro

The Invisibility Report

Your buyers ask an AI before they ask you.

Every week I ask ChatGPT, Perplexity, Gemini and Claude who the best tool in a category is, then publish exactly who showed up, who didn't, and why. Real transcripts, named companies, no summary.

One email a week. Unsubscribe whenever. No pitching.